1. The Antonio G. Olivieri controlled substances therapeutic research program is hereby
established in the department of health. The commissioner shall promulgate rules and regulations necessary for the proper
administration of the controlled substances therapeutic research act. In such promulgation, the commissioner shall take into consideration those pertinent
rules and regulations promulgated by the drug enforcement administration, food and
drug administration and the national institute on drug abuse.
2. Participation in the Antonio G. Olivieri controlled substances therapeutic research
program shall be limited to cancer patients, glaucoma patients and patients afflicted
with other diseases as such diseases are approved by the commissioner. Such patient shall be certified by a physician to and approved by a patient qualification
review board or committee in the manner provided by this article. Physician certification and board or committee approval shall be limited to such
patients who are involved in a life-threatening or sense-threatening situation. Patients seeking participation in such program may seek the advice and shall be
entitled to be advised by appropriate medical personnel concerning the medical efficacy
of treatment with conventional controlled substances.
3. The commissioner, on behalf of the department, shall apply to the food and drug
administration for an investigational new drug permit within ninety days after the
effective date of this section.
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
Was this helpful?
Response sent, thank you
Welcome to FindLaw's Cases & Codes
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.